01 12BDSI
02 3HARM REDUCTION THERP
03 7HIKMA
04 12INDIVIOR
05 54KALEO INC
06 51OREXO US INC
07 6PURDUE PHARMA LP
08 4ZMI PHARMA
01 27731686
02 27731690
03 27749194
04 27947017
05 28016788
06 28021344
07 38147866
08 28206360
09 28226610
10 28231573
11 68470361
12 48475832
13 28627816
14 68658198
15 38703177
16 28926594
17 38939943
18 68940330
19 39022022
20 39073933
21 29238108
22 69259421
23 29278182
24 59439900
25 39474869
26 29517307
27 39522188
28 39522919
29 39655843
30 49687454
31 29724471
32 19814838
33 210143792
34 110143972
35 210220158
36 310322239
37 210335549
38 110722510
39 110874661
40 610946010
41 210960155
42 110973814
43 111020343
44 411020387
45 611020388
46 111027072
47 111135155
48 411135216
49 511433066
50 311571518
51 211590286
52 111617713
53 111628139
54 111806428
55 111975096
56 112414915
57 112458591
01 6Y
02 143Blank
01 133Y
02 16Blank
01 22025-01-15
02 22025-03-21
03 62025-03-30
04 22025-04-30
05 22026-02-01
06 22026-03-31
07 12026-06-01
08 12026-06-10
09 22026-06-25
10 22026-12-12
11 22027-02-20
12 22027-02-27
13 22027-05-23
14 62027-07-23
15 62027-12-03
16 22028-03-12
17 22028-10-30
18 22028-11-25
19 22029-04-10
20 82029-08-07
21 22029-11-02
22 42030-03-26
23 62030-05-22
24 132031-02-28
25 32031-05-24
26 22032-02-04
27 32032-05-11
28 32032-08-20
29 392032-09-18
30 22034-07-18
31 72034-08-26
32 22035-03-20
33 32035-04-24
34 12039-05-24
35 32041-06-14
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8147866
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-1521
Delist Requested :
Patent Use Description : MAINTENANCE TREATMENT ...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-2017
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-2017
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-2017
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8147866
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-1521
Delist Requested :
Patent Use Description : MAINTENANCE TREATMENT ...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8147866
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-1521
Delist Requested :
Patent Use Description : MAINTENANCE TREATMENT ...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2035-04-24
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9522188
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-04-24
Patent Expiration Date : 2032-08-20
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8703177
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-20
Patent Expiration Date : 2035-04-24
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9522188
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-04-24
Patent Expiration Date : 2032-08-20
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8703177
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-20
